SCHEMBL6544649

SCHEMBL6544649

CC(C)C(C)(C)[SiH2]OCCCCCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9862631 1.00
SCHEMBL9862573 1.00
SCHEMBL9862482 1.00
SCHEMBL10753644 0.98
SCHEMBL2935000 0.98
SCHEMBL21220134 0.92
SCHEMBL1226347 0.84
SCHEMBL9517443 0.81
SCHEMBL28102366 0.81
SCHEMBL28102478 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261614-B1 METHOD FOR THE PRODUCTION OF PERBENZYLATED 1-O GLYCOSIDES SCHERING AG (DE) 2004-01-07 EP disclosed
US-6545135-B2 Alkylation SCHERING AKTIENGESELLSCHAFT (DE) 2003-04-08 US disclosed
US-20020002274-A1 Process for the production of perbenzylated 1-0-glycosides SCHERING AKTIENGESELLSCHAFT 2002-01-03 US disclosed
US-6229029-B1 SELECTIVE ESTROGENS EFFECTING BONE, THE CARDIOVASCULAR SYSTEM AND THE CENTRAL NERVOUS SYSTEM; HORMONE REPLACEMENT THERAPY; OSTEOPOROSIS; NO ACTIVITY IN THE UTERUS AND LIVER SCHERING AKTIENGESELLSCHAFT (DE) 2001-05-08 US disclosed